Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Are refugees arriving in Denmark an under-immunised group for measles? A cross-sectional serology study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Impact analysis of rotavirus vaccination in various geographic regions in Western Europe

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Self-reported immunity and opinions on vaccination of hospital personnel among paediatric healthcare workers in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Bacille Calmette-Guérin vaccination at birth and differential white blood cell count in infancy. A randomised clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Introduction of user fee for language interpretation: effects on use of interpreters in Danish health care

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The effect of migration on the incidence and mortality of bloodstream infection: a Danish register-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Health screening among children newly granted asylum in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Anne Mette Fløe Hvass
  • Marie Norredam
  • Morten Sodemann
  • Marianne Kragh Thomsen
  • Wejse Christian
View graph of relations

BACKGROUND: In 2018, Europe faced the highest number of Measles cases in a decade. In Denmark, the childhood vaccination programme has a coverage of approximately 90%. To eliminate the disease, vaccine coverage needs to be above the herd immunity threshold of 95%. This can be even more difficult to obtain, when vaccination programmes break down due to war, natural disasters etc. and concern has been raised, that unvaccinated refugees could facilitate spread of measles when migrating.

METHODS: In order to address this concern, we tested 513 newly arrived refugees and family reunified refugees aged between 0 and 70 years for measles IgG antibodies. The participants were tested as part of a general health assessment between May 2016 and October 2018. In the cohort, 50% were males and the majority came from Syria (55%).

RESULTS: We found that 85% of the total group of refugees had immunity against measles. The 15% lacking antibodies were evenly distributed between the various countries of origin. Moreover, we found immunity to increase with age, leaving young children most vulnerable to infection, 79.9% (<19 years) vs 89.1% (≥19 years). Interview questions on previous vaccinations did not correlate to serology.

CONCLUSION: Refugees have measles immunity slightly lower than the host population.

Original languageEnglish
JournalVaccine
Volume38
Issue number13
Pages (from-to)2788-2794
Number of pages7
ISSN0264-410X
DOIs
Publication statusPublished - 17 Mar 2020

    Research areas

  • Immunisation, Measles, Migrant Health, Refugee, Vaccination

ID: 59422459